Compare DexCom, Inc. (DXCM) vs Emerson Electric Co. (EMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Emerson Electric Co. — how do they compare? DexCom, Inc. trades at $84.11 (market cap $31.86B), while Emerson Electric Co. trades at $161.83 (market cap $88.72B). The key difference: Emerson Electric Co. is far larger — about 2.8× DexCom, Inc.'s market cap, and Emerson Electric Co. pays a 1.4% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold DexCom, Inc. for 62 Days and Emerson Electric Co. for 81 Days on average.
| DXCM | EMR | |
|---|---|---|
Market Cap | $31.86B | $88.72B |
Volume | 3,607,070 | 2,355,255 |
Sector | Health | Industrials |
52-Week High | $92.34 | $164.38 |
52-Week Low | $54.84 | $123.30 |
Typical Hold Time | 62 Days | 81 Days |
Enterprise Value | $31.32B | $99.80B |
Dividend Yield | — | 1.4% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $84.41, showing modest daily gains of 0.13%. The stock demonstrates strong fundamental performance with consistent earnings beats and robust revenue growth, reaching $4.66 billion in 2025. Technical indicators show a bearish short-term trend with key support at $82. The company maintains impressive profitability with 20.12% net margins and 38.49% ROE, supported by growing adoption of CGM technology in diabetes care.
DXCM presents a compelling growth story with expanding market opportunities in Type 2 diabetes care. Analyst consensus remains strongly bullish with 81% buy ratings and $95.07 price target, suggesting 13% upside. Key risks include reimbursement challenges and competitive pressures. The company's strong cash flow generation and institutional support provide solid foundation for continued growth.
Emerson Electric (EMR) trades at $159.06, down 0.1% on the day, with a bullish technical outlook supported by moving averages and a consensus analyst price target of $165.90. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 EPS expected at $1.84. Strong profitability is evident with a 53.16% gross margin and 13.83% net income margin, though valuation multiples like a P/E of 34.81 appear elevated. Recent news highlights momentum and Wall Street optimism.
EMR presents a favorable outlook with earnings momentum and analyst support, but risks include high valuation sensitivity and debt level increases. The stock offers potential upside to the price target, balanced by execution risks in a competitive industrial sector. Investors should weigh solid fundamentals against premium pricing.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Emerson Electric Co.
Emerson Electric is a multi-industrial conglomerate that operates under two business platforms: automation solutions and commercial and residential solutions. The latter is further subdivided into two operating segments: climate technologies, which sells HVAC and refrigeration products and services as well as tools and home products, which sells tools and compressors, among other products and services. Commercial and residential solutions boasts several household brands, including Copeland and RIDGID. Automation solutions is most known for its process manufacturing solutions, which consists of measurement instrumentation, as well as valves and actuators, among other products and services. Roughly half of the firm's geographic sales take place in the United States.
Read more on EMR →
